Related Experiment Video
Updated: Mar 2, 2026
04:29
Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
29.8K
Dual diagnosis in Depression: treatment recommendations
Judit Tirado Muñoz1, Adriana Farré, Joan Mestre-Pintó
1IIMIM-Institut Hospital del Mar. jtirado@imim.es.
Adicciones
|May 12, 2017
Summary
Major depression (MD) and substance use disorders (SUD) frequently co-occur, complicating treatment. An integrated approach is crucial for managing this common dual pathology effectively.
Area of Science:
- Psychiatry
- Addiction Medicine
- Clinical Psychology
Background:
- Comorbidity between substance use disorders (SUD) and major depression (MD) is highly prevalent (12-80%).
- This dual diagnosis complicates treatment response and worsens patient prognosis.
- Distinguishing between substance-induced and primary depressive episodes is critical for effective therapeutic management.
Purpose of the Study:
- To review the current state of pharmacologic treatments for comorbid depression in SUD patients.
- To assess the safety and abuse potential of antidepressant drugs in this population.
- To emphasize the importance of integrated treatment models for co-occurring MD and SUD.
Main Methods:
- Literature review of current pharmacologic treatments for comorbid depression and SUD.
- Analysis of safety profiles and abuse risks associated with antidepressant medications.
- Examination of treatment models for dual diagnosis.
Main Results:
- Pharmacologic treatments for comorbid depression in SUD patients require careful consideration of safety and abuse potential.
- Integrated treatment models are superior to separate treatment approaches for co-occurring MD and SUD.
- Simultaneous management of both conditions is essential for improved outcomes.
Conclusions:
- Integrated treatment is crucial for the frequent comorbidity of major depression and substance use disorders.
- Addressing both conditions concurrently improves psychopathological and medical severity, and social functioning.
- Careful selection of pharmacologic agents is necessary, considering abuse risks.
Related Concept Videos
01:23Antidepressant Drugs: MAOIs and Other Agents
1.1K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.1K
01:24Treatment Strategies for Psychological Disorders
838
Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
838
01:28Drug Therapy
331
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
331
01:18Depression: Overview
1.1K
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
1.1K
01:26Psychosis: Goals of Pharmacotherapy
643
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
643
01:27Depressive Disorders: MDD and Dysthymia
921
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
921